Thursday, August 7, 2025
Science
No Result
View All Result
  • Login
  • HOME
  • SCIENCE NEWS
  • CONTACT US
  • HOME
  • SCIENCE NEWS
  • CONTACT US
No Result
View All Result
Scienmag
No Result
View All Result
Home Science News Cancer

Treatment options for hepatocellular carcinoma using immunotherapy: present and future

May 22, 2024
in Cancer
Reading Time: 3 mins read
0
Treatment Options for Hepatocellular Carcinoma Using Immunotherapy
66
SHARES
597
VIEWS
Share on FacebookShare on Twitter
ADVERTISEMENT

Hepatocellular carcinoma (HCC), a prevalent form of cancer, profoundly influences the progression and prognosis of the disease through immune response mechanisms. The tumor microenvironment plays a pivotal role in fostering immune suppression and maintaining self-tolerance, which are crucial in developing and refining immunotherapy approaches.

Treatment Options for Hepatocellular Carcinoma Using Immunotherapy

Credit: Xun Li, Hongbin Wei, Chunlu Dong

ADVERTISEMENT

Hepatocellular carcinoma (HCC), a prevalent form of cancer, profoundly influences the progression and prognosis of the disease through immune response mechanisms. The tumor microenvironment plays a pivotal role in fostering immune suppression and maintaining self-tolerance, which are crucial in developing and refining immunotherapy approaches.

In our comprehensive review, we initially delve into the characteristics of the tumor microenvironment in HCC, elucidating the predominant immunosuppressive mechanisms at play and the biomarkers pivotal for tracking the disease progression and therapeutic response. Key biomarkers such as α-fetoprotein (AFP), used for diagnosis and monitoring, and emerging molecular markers are extensively discussed.

Central to our discussion is the transformative role of antibody-based therapies, particularly immune checkpoint inhibitors (ICIs). These therapies, which include monoclonal antibodies targeting programmed cell death protein 1 (PD-1), cytotoxic T-lymphocyte-associated protein 4 (CTLA-4), and programmed death-ligand 1 (PD-L1), have revolutionized the approach to HCC treatment. We delve into the specifics of how these therapies reinvigorate the immune system’s ability to recognize and attack tumor cells, discussing their application both as monotherapies and in combination with other targeted therapies. This segment underscores the significance of ICIs in managing advanced HCC, providing new avenues for first-line and subsequent treatments.

Additionally, the review explores various cellular immunotherapies such as T cell receptor (TCR) T cell therapy and chimeric antigen receptor (CAR) T cell therapy. The adaptability of these therapies to individual patient profiles illustrates the shift towards personalized medicine in oncology, aiming to optimize treatment efficacy based on unique tumor characteristics and patient immune profiles.

The potential of HCC vaccines, adjuvant immunotherapy, and oncolytic virotherapy is also thoroughly reviewed. Each of these therapeutic strategies exemplifies cutting-edge advances aiming to prime the immune system more effectively against HCC. We discuss the development stages of various vaccine types, their mechanisms of action, and the potential they hold in preventing recurrence and prolonging patient survival.

In conclusion, our detailed review highlights the dynamic and rapidly evolving landscape of HCC treatment. It reflects on the significant strides made in harnessing the immune system against HCC through innovative immunotherapies and sets the stage for future research that could unlock even more effective treatment modalities. The continuous refinement of immunotherapeutic approaches promises to enhance outcomes for patients with HCC, transforming the prognosis of this challenging cancer.

Full text

 

The study was recently published in the Journal of Clinical and Translational Hepatology.

The Journal of Clinical and Translational Hepatology (JCTH) is owned by the Second Affiliated Hospital of Chongqing Medical University and published by XIA & HE Publishing Inc. JCTH publishes high quality, peer reviewed studies in the translational and clinical human health sciences of liver diseases. JCTH has established high standards for publication of original research, which are characterized by a study’s novelty, quality, and ethical conduct in the scientific process as well as in the communication of the research findings. Each issue includes articles by leading authorities on topics in hepatology that are germane to the most current challenges in the field. Special features include reports on the latest advances in drug development and technology that are relevant to liver diseases. Regular features of JCTH also include editorials, correspondences and invited commentaries on rapidly progressing areas in hepatology. All articles published by JCTH, both solicited and unsolicited, must pass our rigorous peer review process.

Follow us on X: @xiahepublishing

Follow us on LinkedIn: Xia & He Publishing Inc.



Journal

Journal of Clinical and Translational Hepatology

DOI

10.14218/JCTH.2023.00462

Article Title

Treatment Options for Hepatocellular Carcinoma Using Immunotherapy: Present and Future

Article Publication Date

28-Feb-2024

Share26Tweet17
Previous Post

Flexible film senses nearby movements — featured in blink-tracking glasses

Next Post

Bérénice Benayoun (USC) receives Rising Star Award in Aging Research

Related Posts

blank
Cancer

Fetal MRI Reveals Antenatal Subpial Hemorrhage Insights

August 7, 2025
blank
Cancer

First-ever Teaching Textbook on Autophagy Now Available

August 7, 2025
blank
Cancer

Nanoformulation Targets Lung Cancer with Dual Antioxidants

August 7, 2025
blank
Cancer

Exploring Faulty Fetal Packing: Case Studies and Insights

August 7, 2025
blank
Cancer

Bone Metastases Foster Immature Immune Cells, Undermining Immunotherapy Effectiveness

August 7, 2025
blank
Cancer

Anatomical Partitioning Reveals Neurogenic Tumor Origins

August 7, 2025
Next Post
Bérénice Benayoun, PhD,

Bérénice Benayoun (USC) receives Rising Star Award in Aging Research

  • Mothers who receive childcare support from maternal grandparents show more parental warmth, finds NTU Singapore study

    Mothers who receive childcare support from maternal grandparents show more parental warmth, finds NTU Singapore study

    27530 shares
    Share 11009 Tweet 6881
  • University of Seville Breaks 120-Year-Old Mystery, Revises a Key Einstein Concept

    942 shares
    Share 377 Tweet 236
  • Bee body mass, pathogens and local climate influence heat tolerance

    641 shares
    Share 256 Tweet 160
  • Researchers record first-ever images and data of a shark experiencing a boat strike

    506 shares
    Share 202 Tweet 127
  • Warm seawater speeding up melting of ‘Doomsday Glacier,’ scientists warn

    310 shares
    Share 124 Tweet 78
Science

Embark on a thrilling journey of discovery with Scienmag.com—your ultimate source for cutting-edge breakthroughs. Immerse yourself in a world where curiosity knows no limits and tomorrow’s possibilities become today’s reality!

RECENT NEWS

  • Cellulose Acetate Boosts Performance in Solid-State Electrolytes
  • Fetal MRI Reveals Antenatal Subpial Hemorrhage Insights
  • Glacier Perito Moreno: A Study in Climate Change
  • Turbulence Impact on Coral Reef Zooplanktivorous Fish

Categories

  • Agriculture
  • Anthropology
  • Archaeology
  • Athmospheric
  • Biology
  • Bussines
  • Cancer
  • Chemistry
  • Climate
  • Earth Science
  • Marine
  • Mathematics
  • Medicine
  • Pediatry
  • Policy
  • Psychology & Psychiatry
  • Science Education
  • Social Science
  • Space
  • Technology and Engineering

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 4,859 other subscribers

© 2025 Scienmag - Science Magazine

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • HOME
  • SCIENCE NEWS
  • CONTACT US

© 2025 Scienmag - Science Magazine

Discover more from Science

Subscribe now to keep reading and get access to the full archive.

Continue reading